US Patent 10882907 Multispecific antibodies that target HIV GP120 and CD3
Patent 10882907 was granted and assigned to Gilead Sciences on January, 2021 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 21, 2018
Date of Patent
January 5, 2021
Patent Applicant
Patent Application Number
16014153
Patent Citations
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 10882907 Multispecific antibodies that target HIV GP120 and CD3
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.